What future for European biomonitoring?
HEAL’s Genon K. Jensen and Lisette van Vliet, are among the co-authors of an article setting out policy recommendations on European human biomonitoring (HBM) in the latest journal edition of ‘Environmental Research’.
The article entitled ‘Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys’ presents a framework for a sustainable HBM structure in Europe building on stakeholder activities and national engagement during the past 10 years. The structure would involve national institutions in the fields of environment, health and food as well as the European agencies including the European Chemicals Agency (ECHA), the European Environment Agency (EEA) and the European Food Safety Authority (EFSA).
Genon K. Jensen, HEAL Executive Director and Lisette van Vliet, HEAL Senior Advisor on Chemicals and Chronic Disease Prevention highlight the future potential of HBM and the major policy needs of specified stakeholders in this area. They also highlight how regular human exposure assessment in Europe could be brought in line with international actions.
The article estimates costs on the basis of the experience of the pilot phase, and suggests cost sharing implications for national and European institutions based on the existing framework set up by COPHES/DEMOCOPHES, the Consortium to Perform Human biomonitoring.
Originally posted on 17 September 2015